Learn the correct cagrilintide pronunciation, syllable by syllable, plus how to say CagriSema and why the -tide ending in peptide names rhymes with "tide."
The short answer: cagrilintide is pronounced "kag-rih-LIN-tide" — four syllables, with the stress on the third. The final syllable rhymes with the word "tide," exactly as it does in pramlintide and semaglutide. You will hear that version most often in trial readouts, medical podcasts, and materials from Novo Nordisk, the drug's developer.
People who type "cagrilintide pronounce" into a search bar are usually after the same thing: a version they can say out loud without hesitating. Here is the breakdown.
Cagrilintide Pronunciation, Syllable by Syllable
Breaking the name into four pieces is the fastest way to get it right. Say each syllable slowly, then speed up until it sounds natural.
| Syllable | Sounds like | Notes |
|---|---|---|
| Cag | "kag" | Hard K and a short a, as in "cat" |
| ri | "rih" | Short i, unstressed; think "rib" without the b |
| lin | "LIN" | The primary stress lands here |
| tide | "tide" | Rhymes with "wide" and "ride" |
All together: kag-rih-LIN-tide. In rough IPA that is /ˌkæɡ.rɪˈlɪn.taɪd/. There is no silent letter and no hidden syllable — the word has exactly four.
Practice Tips
- Say "pramlintide" first (PRAM-lin-tide), then swap the front. The rhythm is identical.
- Slow down on the third syllable. "LIN" is where most people rush and stumble.
- Listen to one conference recording or podcast clip and repeat the name three times out loud.
- Do not add an extra syllable. It is kag-rih-LIN-tide, not kag-rih-lin-i-tide.
Why the "-tide" Ending Always Rhymes With "Tide"
"-tide" is the standard suffix for peptide drugs, which is why so many of these names sound alike. In every name that uses it, the ending rhymes with "ride" — never "tid," "teed," or "tide-ee."
| Drug Name | Common Pronunciation |
|---|---|
| Semaglutide | sem-a-GLOO-tide |
| Tirzepatide | tir-ZEP-a-tide |
| Liraglutide | lir-a-GLOO-tide |
| Pramlintide | PRAM-lin-tide |
| Cagrilintide | kag-rih-LIN-tide |
The stressed syllable moves around within this family, but the last syllable never does. That single rule gets you most of the way through any unfamiliar peptide name you meet.
How to Say CagriSema and Other Variations You'll Hear
CagriSema is the combination of cagrilintide and semaglutide, and it is the name that shows up most in headlines. Say it "kag-rih-SEE-muh," with the stress on the third syllable. Some speakers land on "kag-rih-SEM-uh," and both are understood in conversation.
American and British speakers mostly agree on this name, which is not always true for drug names. A few variations still turn up:
- KAG-rih-lin-tide — stress on the first syllable, common among people reading the word for the first time.
- ka-GRIL-in-tide — stress on the second syllable, heard from some clinicians and podcast hosts.
- "Cagri" — the everyday shorthand, pronounced "KAG-ree."
None of those will get you corrected, but "kag-rih-LIN-tide" is the version that matches the drug's naming conventions, so it is the safest choice in a professional setting.
What Cagrilintide Is and Why People Look It Up
Cagrilintide is an investigational amylin analog developed by Novo Nordisk. It acts on amylin receptors, which are involved in appetite regulation and gastric emptying, and researchers are studying it mainly for obesity and type 2 diabetes.
Most searches for the pronunciation come from people who read the name in clinical trial coverage or heard it on a podcast and want to say it correctly — in a meeting, a class, or a video. Readers who look up cagrilintide dosage or the CagriSema phase 3 results tend to run into the pronunciation question at the same moment.
Is Cagrilintide FDA-Approved in the US?
No. As of 2025, cagrilintide is not FDA-approved for human use in the United States as a standalone product. Novo Nordisk has been developing it primarily in combination with semaglutide under the name CagriSema and has signaled that it intends to pursue regulatory approval.
Cagrilintide is a prescription drug candidate, not a research peptide that can be legally sold online. Product marketed as "cagrilintide" today is unapproved and unverified, which carries real safety risks. Anyone considering a weight-management medication should talk with a licensed healthcare professional instead of sourcing it themselves.
Peptide Names People Search Alongside It
The audience for cagrilintide news overlaps heavily with the research-peptide crowd, even though the two worlds sit under very different rules. A search like does bpc-157 help with muscle growth is asking a biology question about a compound that is not FDA-approved at all, while someone checking how to say cagrilintide is usually just reading drug-development news.
You can see the overlap in the queries themselves. Searches such as how does igf 1 lr3 work and does kpv help with weight loss come from people exploring peptides broadly, while a query like where to buy bpc-157 and tb-500 points to the gray market for research chemicals. None of those compounds are approved for human use in the United States.
If the name ever feels awkward to say, remember that most people hearing it are learning it at the same time you are. It entered everyday conversation only recently.
Frequently Asked Questions
How do you pronounce cagrilintide?
Say "kag-rih-LIN-tide," with the stress on the third syllable and the ending rhyming with "tide." The pattern matches pramlintide (PRAM-lin-tide) and semaglutide (sem-a-GLOO-tide). Some clinicians put the stress on the second syllable instead, but the four-syllable structure stays the same.
Is cagrilintide FDA-approved in the United States?
No. As of 2025, cagrilintide is not FDA-approved for human use in the United States as a standalone drug. It is an investigational amylin analog that Novo Nordisk is developing, mainly in combination with semaglutide as CagriSema. Any product marketed as cagrilintide today is unapproved and unverified.
Is cagrilintide the same as CagriSema?
No. CagriSema is a combination product containing both cagrilintide and semaglutide, while cagrilintide is a single amylin analog. CagriSema is pronounced "kag-rih-SEE-muh." The two names get used interchangeably in headlines, but they are not the same thing.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.